Notícias Daiichi Sankyo Company Ltd (PK) - DSNKY | Ações OTCMarkets | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Daiichi Sankyo Company Ltd (PK) (DSNKY)
Daiichi Sankyo Company Ltd (PK) (DSNKY) Notícias

Daiichi Sankyo Company Ltd (PK) (DSNKY)

32,598

0,848

( 2,67% )

Atualizado: 16:52:32

Atrasado por 15 minutos

Seu centro para cotações em tempo real, discussões ao vivo e novas ideias.

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular ...

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge

Daiichi Sankyo and Ambit Announce Results of Tender Offer

Announcement Regarding Submission of Tender Offer for Shares in Ambit Biosciences Corporation

Daiichi Sankyo to Acquire Ambit Biosciences

Daiichi Sankyo to Acquire Ambit Biosciences

Daiichi Sankyo to Acquire Ambit Biosciences

Daiichi Sankyo Further Expands TaNeDS Collaborative Drug Discovery Program in Europe

Daiichi Sankyo Further Expands TaNeDS Collaborative Drug Discovery Program in Europe

Daiichi Sankyo and Charleston Laboratories Announce Collaboration to Develop and Commercialize Novel, Fixed-Dose Combination ...

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-...

Daiichi Sankyo and Lilly Announce TRILOGY ACS Results Regarding Effient® (Prasugrel) in Acute Coronary Syndrome UA/NSTEMI Pa...

Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma Presented at ASCO

Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma Presented at ASCO

Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma to be Presented at ASCO

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Daiichi Sankyo (PK)

Granite 3xs Dge

Lyxor Asset Management L...

BNP Paribas Issuance

EURO STOXX 50 -3X Daily ...

Regency Centers

Cabinda Participacoes ON

Invesco EUR Corporate Bo...

Dell Technologies

BNP Paribas Issuance

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições